Clin J Am Soc Nephrol 2015;10:2136e42
When to Delay Dose Escalation Hold your current retatrutide dose and don't escalate if you experience: Persistent nausea or vomiting (more than 3 days after injection) Severe constipation or diarrhea Significant injection site reactions Rapid weight loss (more than 3-4 lbs/week consistently) Signs of dehydration from GI symptoms It's acceptable to remain at a dose longer than 4 weeks if needed
Owing to the recent increase in the prevalence of prediabetes, diabetes, obesity, and abdominal obesity among young adults under the age of 40 [1,7], there have been suggestions for a change in previous screening criteria for diabetes (adults aged 40 and adults aged 30 years with risk factors) [2]
The core of the lawsuit alleges that Novo Nordisk and Eli Lilly, the manufacturers of these drugs, failed to provide sufficient warnings about potential severe gastrointestinal side effects
Dosing should be individualized
Retatrutide (8 mg) led to peak plasma concentrations of 874 ng/ml (182 nM) (Coskun et al